Skip to main content

editorial

. 2006 Dec 5;26(4):161–162. doi: 10.1002/clc.4960260402

Partial fatty acid oxidation (pFOX) inhibition: A new therapy for chronic stable angina

C Richard Conti

PMCID: PMC6654658 PMID: 12708620

Full Text

The Full Text of this article is available as a PDF (27.4 KB).

References

1. Schofield RS, Hill JA: Role of metabolically active drugs in the management of ischemic heart disease. Am J Cardiovasc Drugs 2001; 1: 23–35 [DOI] [PubMed] [Google Scholar]
2. Schofield RS, Hill JA: The use of ranolazine in cardiovascular disease. Expert Opin Investig Drugs 2002; 11(1): 117–123 [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES